Article Information
History
- April 19, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Joseph A. Lewnard1,*,
- Parag Mahale2,
- Debbie Malden2,
- Vennis Hong2,
- Bradley K. Ackerson2,
- Bruno J. Lewin2,
- Ruth Link-Gelles3,
- Leora R. Feldstein4,
- Marc Lipsitch4 and
- Sara Y. Tartof2,5
- 1School of Public Health, University of California, Berkeley, Berkeley, California, United States
- 2Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, United States
- 3Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control & Prevention, Atlanta, Georgia, United States
- 4COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, United States
- 5Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, United States
- ↵*Address for correspondence: Joseph A. Lewnard, Room 5410, 2121 Berkeley Way, Berkeley, California 94720 jLewnard{at}berkeley.edu Tel.: 510-664-4050
Posted April 19, 2024.
Immune escape and attenuated severity associated with the SARS-CoV-2 BA.2.86/JN.1 lineage
